Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Repurchased (2016 - 2022)

Catalyst Pharmaceuticals' Shares Repurchased history spans 5 years, with the latest figure at $7000.0 for Q3 2022.

  • For Q3 2022, Shares Repurchased fell 99.86% year-over-year to $7000.0; the TTM value through Mar 2023 reached $4.4 million, down 69.47%, while the annual FY2025 figure was $25.3 million, N/A changed from the prior year.
  • Shares Repurchased reached $7000.0 in Q3 2022 per CPRX's latest filing, down from $4.4 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $5.1 million in Q3 2021 to a low of $7000.0 in Q3 2022.